Just in case you missed BIOPLUS-INTERPHEX KOREA 2020 Conference,
 Conference VODs will be available on the BIOTV Youtube channel from October 14 to November 28.

*Please note that presentations only permitted by speakers are uploaded.

VOD 2nd Line-up (As of October 21)

CLICK here to download the presentation file

Cell & Gene therapy coming of age: Opportunities and challenges to getting ahead

When it comes to diseases which have no cure or unmet needs, a gene or a cell therapy can be an attractive choice as the next generation medicine considering its merits such as shorter treatment period and higher effectiveness. Yet, it also comes with some challenges in terms of policy, cost and immune response. This session is going to talk about a few possible measures we can think of against such challenges.

CLICK here to download the presentation file

Biopharma Logistics Trends & Solutions

Since the outbreak of the COVID-19 pandemic, the cold chain logistics has received more attention than ever due to the increasing demand of delivering vaccines and kits. Throughout the session, a variety of topics relating to the latest information on cold chain logistics and other relevant practical advises, which people working in the pharmaceutical field must know, is going to be shared - from the current status of the cold chain logistics industry, packaging solutions, delivery monitoring schemes, shipping validation strategies to blockchain technologies to be commercialized in the near future.

CLICK here to download the presentation file

Brain Health: Innovative approach to CNS drug development

Unlike the anticancer areas which have made gradual progresses thanks to the development of the CAR-T and immunotherapies, the CNS (central nervous system) still remains as an unconquered and uncharted territory. Many fields of the CNS diseases have not discovered a perfect treatment yet, meaning that a success in developing an innovative new drug in those fields will highly likely to guarantee a significant competitive edge in the global market. This session is going to discuss multiple approaches on how to make a success in developing new drugs.

CLICK here to download the presentation file

Global License Strategy: Looking into the Future

COVID-19 has changed the world dramatically, while biotech industry has been playing a major role in managing the global crisis. The future requires companies in the industry around the globe to work together more than ever. In this session, biotech company COEs and field experts will share their learning and experience with you.

CLICK here to download the presentation file

Bio Start-up Discovery

The cradle of start-ups! Meet incubators, builders, and accretors at once in this session and hear out what these essential nutrients for start-ups have to say on the critical success factors for start-ups.

CLICK here to download the presentation file

Asian Market Strategy

This session is to share bio policies and the status of the biotech industry at major Asian countries and to share the cases of companies that have successfully entered each country.

CLICK here to download the presentation file

Enhancement of Bio Industry Production & Developement of Next Generation Advanced New Material Technology

CLICK here to download the presentation file

Open Innovation: Global Alliance Partnership

Are you a Korean bio-venture company looking for an investment from or joint research with a multinational pharmaceutical company? Come and join here then! Who are the partners being sought by Novartis, Merk, J&J, and Sanofi? Seek and grab the opportunity to look into the famous big pharma's open innovation strategies with aspirational Bio-venture companies. Want to learn?

 

CLICK here to download the presentation file

There are a variety of ways in which Korean firms can enter the world’s largest bio-health market. Licensing, partnering, joint ventures and green field investments are options that require careful planning and due diligence. This 1.5-hour seminar, organized by the U.S. Embassy Seoul and six U.S. States (GA, LA, OH, PA, TN, VA), will feature presentations by experts on the U.S. life sciences market, market entry strategies, and the regulatory environment. Whether your firm is exporting to the U.S., or looking to invest millions of dollars in an R&D facility, this seminar will provide you with information to help your business enter and expand into the United States. The United States is the largest market for biopharmaceuticals, accounting for around a third of the global market, and is the world leader in biopharmaceutical R&D. Additional reasons why your company should invest in the United States includes 330 million consumers, strong intellectual property protection and a fair and transparent business environment.

CLICK here to download the presentation file

How to Go Global: Challenges & Considerations

Most-anticipated new drugs of the previous year have produced a clinical trial outcome below expectation one after another, making domestic biopharmaceutical and bio companies feel daunted. Despite encountering a failure in the third phase, they again embarke on the design of a new trial, adding fresh fuel to the development of new drugs. This session will share the lessons learned from the third phase global trials, the rebound efforts made afterwards, and the clinical designs required to improve the success rate.

 

CLICK here to download the presentation file

Strategy to Korean Initial Public Offering

Status of Listing in KOSDAQ, Listing Procedures, Listing Evaluation Procedures, Evaluation Criteria (Quantitative/Qualitative Requirements), Differences between Listing Types, Fast-track Listing Transfer Program, Major Issues in Qualitative Evaluation, Technology Evaluation-based Preferential Listing Policy, and Recent Major Institutional Improvements - Class 101 for all Bio start-ups looking forward to KODAQ listing.